These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 25445397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.
    Loskove Y, Yasuda M, Chen B, Nazarenko I, Cody N, Desnick RJ.
    Mol Genet Metab; 2019 Nov; 128(3):352-357. PubMed ID: 30385147
    [Abstract] [Full Text] [Related]

  • 3. Hepatocellular carcinoma in variegate porphyria: a serious complication.
    Schneider-Yin X, van Tuyll van Serooskerken AM, Went P, Tyblewski W, Poblete-Gutiérrez P, Minder EI, Frank J.
    Acta Derm Venereol; 2010 Sep; 90(5):512-5. PubMed ID: 20814629
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate.
    Ausenda S, Di Pierro E, Brancaleoni V, Besana V, Cappellini MD.
    Hum Genet; 2007 Nov; 122(3-4):417. PubMed ID: 18350656
    [No Abstract] [Full Text] [Related]

  • 7. Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
    Molina L, Zhu J, Trépo E, Bayard Q, Amaddeo G, GENTHEP Consortium, Blanc JF, Calderaro J, Ma X, Zucman-Rossi J, Letouzé E.
    J Hepatol; 2022 Oct; 77(4):1038-1046. PubMed ID: 35636578
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis.
    Tabaro I, Reimondo G, Osella G, Aurizi C, Caraci P, Barbieri L, Giachino DF, Sirchia F, Terzolo M.
    Endocrine; 2018 Sep; 61(3):403-406. PubMed ID: 29516370
    [Abstract] [Full Text] [Related]

  • 12. Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.
    Ferrer MD, Mestre-Alfaro A, Martínez-Tomé M, Carrera-Quintanar L, Capó X, Jiménez-Monreal AM, García-Diz L, Roche E, Murcia MA, Tur JA, Pons A.
    PLoS One; 2016 Sep; 11(10):e0164857. PubMed ID: 27788171
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic and biochemical studies in Argentinean patients with variegate porphyria.
    Rossetti MV, Granata BX, Giudice J, Parera VE, Batlle A.
    BMC Med Genet; 2008 Jun 20; 9():54. PubMed ID: 18570668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Review: molecular pathogenesis of hepatic acute porphyrias.
    Grandchamp B, Puy H, Lamoril J, Deybach JC, Nordmann Y.
    J Gastroenterol Hepatol; 1996 Nov 20; 11(11):1046-52. PubMed ID: 8985829
    [Abstract] [Full Text] [Related]

  • 19. Overrepresentation of the founder PPOX gene mutation R59W in a South African patient with severe clinical manifestation of porphyria.
    de Villiers JN, Kotze MJ, van Heerden CJ, Sadie A, Gardner HF, Liebenberg J, van Zyl R, du Plessis L, Kimberg M, Frank J, Warnich L.
    Exp Dermatol; 2005 Jan 20; 14(1):50-5. PubMed ID: 15660919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.